Stem cells (Dayton, Ohio)
Circadian Timing Optimizes Allo-HSCT to Prevent aGVHD: A Breakthrough in Chrono-Immunotherapy.
Xiaguang Huang, Hening Xu, Yanru Xia, Zeshan Lu, Shiwei Duan, Yongming Xia
Published: 202610.1093/stmcls/sxaf084
Abstract
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely regarded as the most potent curative cell therapy for a range of malignancies, particularly hematologic cancers. However, its clinical application remains significantly constrai…
Preview only. Read the full abstract at the source